menu
    • menu

    Company profile for Zymeworks

    NEW Drugs in Dev: 6
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zymeworks has developed the ZymeCAD™ molecular simulation engine for protein modeling and structure-guided optimization with the unparalleled ability to relate the functional and biophysical characteristics of a protein to its structure. The proprietary insight generated by the ZymeCAD™ engine enables Zymeworks to engineer knowledge-based structural modifications that result in new or improved protein-based drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZymeworksCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1385 West 8th Avenue, Suite 540 Vancouver, BC, Canada V6H 3V9
    Telephone
    Telephone
    (604) 678-1388
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zymeworks.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zymeworks Announces $125M Share Repurchase Program
    Zymeworks Announces $125M Share Repurchase Program

    14 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/14/3295346/0/en/zymeworks-announces-share-repurchase-program-of-up-to-125-million-of-its-common-stock.html

    GLOBENEWSWIRE
    14 May 2026
    Share Share
    Zymeworks To Participate In Investor Conferences
    Zymeworks To Participate In Investor Conferences

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293774/0/en/zymeworks-announces-participation-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Zymeworks Reports Q1 2026 Results and Corporate Update
    Zymeworks Reports Q1 2026 Results and Corporate Update

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290579/0/en/zymeworks-provides-corporate-update-and-reports-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Zymeworks Unveils ZW191, Phase 1 Data At AACR 2026 Meeting
    Zymeworks Unveils ZW191, Phase 1 Data At AACR 2026 Meeting

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278571/0/en/zymeworks-presents-new-phase-1-data-for-zw191-a-folate-receptor-alpha-targeting-adc-at-aacr-annual-meeting-2026.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Zymeworks Unveils Preclinical Data on Novel RAS-Targeting ADCs
    Zymeworks Unveils Preclinical Data on Novel RAS-Targeting ADCs

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187980

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Zymeworks Reports Q1 2026 Results, Hosts Call on May 7
    Zymeworks Reports Q1 2026 Results, Hosts Call on May 7

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275119/0/en/Zymeworks-to-Report-First-Quarter-2026-Financial-Results-and-Host-Conference-Call-on-May-7-2026.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search